Tibor H.
- Country
- Slovakia
- Department
- Gastroenterológia
Research Overview
- Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Duvakitug for Induction Therapy in Moderately to Severely Active Crohn's Disease
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Ulcerative Colitis
- Long-Term Efficacy and Safety Evaluation of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis: A Phase 3, Multicenter, Open-Label Extension Study
Data & Insights
Has run more than one trial at 374 of 565 partner sites.
Specializations
Ulcerative Colitis Research
The investigator specializes in treating moderate to severe ulcerative colitis, with particular focus on evaluating novel therapeutic approaches and long-term treatment strategies.
- Innovative biologics assessment
- Maintenance therapy evaluation
- Bowel urgency management
Their work includes investigating combination therapies and biosimilar treatments for enhanced clinical outcomes in ulcerative colitis patients.
Crohn's Disease Studies
The investigator conducts extensive research in moderately to severely active Crohn's disease, focusing on developing and evaluating new therapeutic options.
- Endoscopic response assessment
- Long-term efficacy studies
- Oral therapeutic development
Their research encompasses maintenance therapy strategies and innovative treatment approaches for Crohn's disease management.
Inflammatory Bowel Disease Therapeutics
The investigator's work extends to broad inflammatory bowel disease (IBD) treatment development, including both established and experimental therapeutic approaches.
- Novel drug formulations
- Clinical remission studies
- Long-term safety evaluations
Their research includes investigating subcutaneous and oral administration routes for various IBD treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.